All Stories

  1. Utility of Palladium as a Catalyst for the Synthesis of Five and Six-Membered Heterocyclic Moieties
  2. Catalytic, Green-Synthetic, and Rearrangement Strategies for Biologically Active Piperazine Derivatives
  3. PROTACs in Oncology: Emerging Frontiers for Next-Generation Cancer Therapeutics
  4. Sharpless Asymmetric Epoxidation: Mechanism, and Applications in the Stereoselective Synthesis of Natural Products and Bioactive Molecules
  5. Advances in Chemotherapeutic Potential of Glycoconjugates against Cancer
  6. Rechallenge Therapy: New Dimensions in Cancer Therapy
  7. Synthesis, in-vivo, ADMET prediction, molecular docking studies, MD simulation, and DFT analysis of novel 1,3,4-oxadiazole-furan hybrids as anticonvulsants
  8. Advances in Synthesis of Piperazine Analogues and Molecular Targets: Unlocking Their Potential in CNS Disorder Therapy
  9. Copper-catalyzed synthesis of heterocycles via single and two-electron pathways
  10. Synthesis and Structure-Activity Relationship of Pyrazoline Derivatives for Antimicrobial Applications: Current Insights
  11. Synergistic Anti-dementia Effects of Symplocos racemosa Nanoemulsion: Isolation, Molecular Docking, and In Vivo Evaluation
  12. Recent Advances in Multicomponent Reactions for Pyrrolidine Derivative Synthesis: Catalytic, Catalyst-Free, and Azomethine Ylide Approaches
  13. Unlocking the Potential of Polysaccharides for the Treatment of Lung Cancer
  14. Zwitterion: Important Tool for the Regioselective Synthesis of Five‑Membered Heterocycles: Mechanistic and Synthetic Perspectives
  15. Recent Trends in the Synthesis of Benzimidazoles and Use of the Phillips Modification. A Review
  16. Advances in the Synthesis and Therapeutic Exploration of Pyrazole/Pyrazoline- Bearing Benzimidazoles: Searching for New Lead Compounds
  17. Ludwig Knorr’s synthesis: Advances in heterocyclic synthesis of quinoline, quinolone, pyrazole, and pyrrole derivatives
  18. Targeting the NLRP3 inflammasome with natural products for ischemia–reperfusion injury across organs: mechanisms, structure–activity relationships, and delivery innovations
  19. Design, synthesis, in silico and in vivo evaluation of 1,3,4-oxadiazoles as anticonvulsant agents
  20. Advances in Medicinal Chemistry of Fused and Substituted Piperazines: Unlocking their Potential as Anticancer Agents
  21. Optimized Strategies for the Synthesis and Structure-Activity Relationship of Imidazole as an Antiepileptic Drug
  22. Hyperemesis Gravidarum: Causes, Symptoms, and Management
  23. Significant advances in catalytic strategies for the synthesis of trisubstituted imidazoles: a review
  24. Innovative Synthesis of 3,5-Disubstituted Pyrazoline with Heterocyclic System for Hybrid Development
  25. Integration of In-vivo screening, molecular docking, and molecular dynamics simulations for studying the antiepileptic potential of newly synthesized 5-naphthalen-1-yl-5,10-dihydro-1H-pyrimido[4,5-b]quinoline-2,4-diones in optimized reaction conditions...
  26. Fused and Substituted Piperazines as Anticancer Agents: A Review
  27. Synthesis, Pharmacological Activities, Structure-activity Relationship of 1,3,4-Oxadiazole-Piperazine Conjugates: A Review
  28. Quinoline and Analogs: Insight into the Synthesis, Biological Activity, Structure-Activity Relationship, and Interaction with Targets
  29. Hybrids of Benzimidazole-oxadiazole: A New Avenue for Synthesis, Pharmacological Activity and Recent Patents for the Development of More Effective Ligands
  30. Oxidative Coupling: An Important Tool for Pyrrole Synthesis
  31. The Catalysts-Based Synthetic Approaches to Quinolines: A Review
  32. Synthesis, in vitro, ADME Prediction, and Molecular Docking Studies of 1,3,4-Oxadiazole-piperazine Conjugates as New Anti-tubercular Agents
  33. Synthesis, in vivo, ADME, and molecular docking studies of 1,3,4-oxadiazole-pyridine conjugates as new anti-convulsant agents
  34. Pyrazoline and Analogs: Substrate-based Synthetic Strategies
  35. Quinoline-hydrazone Conjugates: Recent Insights into Synthetic Strategies, Structure-activity Relationship, and Biological Activities
  36. Synthesis, In Vivo, ADME Determination, and Molecular Docking Studies of 1,3,4‐Oxadiazoles Containing Pyridine and Piperazine Moieties as New Diuretic Agents
  37. Synthesis of Pyridines/Dihydropyridines via Hantzsch Reaction, Structure-activity Relationship and Interactions with Targets: A Review
  38. A review on innovative approaches in quinoline/isoquinoline synthesis: Unveiling the Pummerer reaction strategy
  39. Pharmacological Evaluation of Bioisosterically Replaced and TriazoleTethered Derivatives for Anticancer Therapy
  40. Hydrazides: An Important Tool for the Synthesis of 1,3,4-Oxadiazole
  41. Synthesis, in vitro, in silico, and molecular docking studies of some new benzothiazole-linked pyrazoline derivatives as orally administered beta-ketoacyl-ACP synthase III and malonyl-CoA inhibitors
  42. 1,3,4-Oxadiazoles as Anticancer Agents: A Review
  43. Recently Adopted Synthetic Protocols for Piperazines: A Review
  44. Synthesis, In vivo, and In silico Evaluation of New Pyrazoline‐Benzothiazole Conjugates as Antiepileptic Agents
  45. Hantzsch reaction: The important key for pyridine/dihydropyridine synthesis
  46. Recent Advances in Synthetic Strategies of Piperazine & its Analogs Via Rearrangement Reactions: A Review
  47. Insight into the Synthesis, Biological Activity, and Structure-activity Relationship of 1,2,4-Oxadiazole and Analogs: A Comprehensive Review
  48. Recent Innovations in Synthetic Methodologies and Patent Landscape of Quinoline Analogues: A Comprehensive Review
  49. Substrate‐based synthetic strategies and biological activities of 1,3,4‐oxadiazole: A review
  50. The medicinal chemistry of piperazines: A review
  51. Rearrangement reactions: Important tool for the synthesis of piperazines
  52. Synthetic Protocols, Structural Activity Relationship, and Biological Activity of Piperazine and its Derivatives
  53. Targeted Development of Pyrazoline Derivatives for Neurological Disorders: A Review
  54. Synthetic Strategies of Thiazolidine-2,4-dione Derivatives for the Development of New Anti-diabetic Agents: Compressive Review
  55. Synthesis, Characterization, in silico and in vivo Evaluation of Amino Acid Derived Schiff Bases of Quinoline-Benzimidazole Hybrids as Anti-epileptic Agents
  56. Protein kinase inhibitors in the management of cancer: therapeutic opportunities from natural compounds
  57. Synthetic Strategies of Pyrazoline Derivatives for the Development of New Anticancer Agents: Recent Updates
  58. Synthetic Protocols and Applications of 1,2,5-Oxadiazoles: A Review
  59. Recently Adopted Synthetic Approaches to Pyridine and Analogs: A Review
  60. Recent Updates on Synthesis, Biological Activity, and Structure-activity Relationship of 1,3,4-Oxadiazole-quinoline Hybrids: A Review
  61. An Exquisite Analysis on the Significance of Nutrient Supplementation in the Holistic Management of Poly-cystic Ovarian Syndrome
  62. Updates on the Synthetic Strategies and Structure-Activity Relationship of Anticonvulsant Benzothiazole and Benzimidazole Derivatives
  63. Synthesis and SAR of Potential Anti-Cancer Agents of Quinoline Analogues: A Review
  64. Significant Advancement in Various Synthetic Strategies and Pharmacotherapy of Piperine Derivatives: A Review
  65. Insights into adopted synthetic approaches for 1,2,4-oxadiazoles: A review
  66. Insights Into the Synthetic Strategies, Biological Activity, and Structure- Activity Relationship of Pyridine and Analogs: A Review
  67. Screening of Neuroprotective Action of Hydroethanolic Extract of Leaf of <i>Clematis buchananiana</i> in Diabetic-Induced Neuropathy
  68. An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers
  69. 1,3,4-Oxadiazole and its Analogs: Recently Adopted Synthetic Approaches and Interaction with Targets
  70. Synthetic approaches and applications of an underprivileged 1,2,5‐oxadiazole moiety: A review
  71. A Review on Synthetic Strategies for Useful Oxadiazole Derivatives in Psychological Disorders
  72. Synthesis, Characterization, In Silico and In Vivo Evaluation of Benzimidazole‐Bearing Quinoline Schiff Bases as New Anticonvulsant Agents
  73. Recent Insights on Synthetic Methods and Pharmacological Potential in Relation with Structure of Benzothiazoles
  74. Synthesis of pyrazolines via 1,3-dipolar cycloaddition reactions
  75. Camphor and Menthol as Anticancer Agents: Synthesis, Structure-Activity Relationship and Interaction with Cancer Cell Lines
  76. Synthetic Approaches, Biological Activities, and Structure–Activity Relationship of Pyrazolines and Related Derivatives
  77. Current Developments in Synthetic Protocols for Pyrazolines and Analogs
  78. Synthesis Anticonvulsant and Cytotoxic Evaluation of Benzimidazole-Quinoline Hybrids Schiff Base Analogs
  79. Insight into the Synthesis, Biological Activity, and Structure-activity Relationship of Benzothiazole and Benzothiazole-hydrazone Derivatives: A Comprehensive Review
  80. Synthesis, Structure-Activity Relationship, and Biological Activity of Benzimidazole-Quinoline: A Review to Aid in the Design of a New Drug
  81. WITHDRAWN: Recent Advancement on Various Synthetic Strategies and Pharmacotherapy of Piperine and its Derivatives
  82. Synthesis, Anticonvulsant, and Molecular Docking Studies of (3,5-disubstituted-4,5-dihydro-1H-pyrazol-1-yl) (4-chlorophenyl) Methanone Derivatives
  83. Design, Synthesis, In Vivo, and In Silico Evaluation of Benzothiazoles Bearing a 1,3,4-Oxadiazole Moiety as New Antiepileptic Agents
  84. Molecular target interactions of quinoline derivatives as anticancer agents: A review
  85. A Comprehensive Review on Synthetic Approaches and Biological Activities of 1,3,4-oxadiazole
  86. Review on the discovery of new Benzimidazole derivatives as Anticancer Agents: Synthesis and Structure-Activity Relationship (2010-2022)
  87. Recent Advances in Synthetic Strategies of Benzimidazole and its Analogs: A Review
  88. Recent Updates on Synthetic Strategies and Biological Potential of 1,3,4- oxadiazole: Review
  89. Design, synthesis, in vivo and in silico evaluation of novel benzothiazole-hydrazone derivatives as new antiepileptic agents
  90. Synthetic Approach to Potential Anticancer Benzimidazole Derivatives: A Review
  91. Benzothiazole: Synthetic Strategies, Biological Potential, and Interactions with Targets
  92. Insights into Interactions of Human Cytochrome P450 17A1: A Review
  93. Pyridine Moiety: An Insight into Recent Advances in the Treatment of Cancer
  94. Anti-Diabetic Potentials of Thiazolidinedione Analogues with Efficient Synthetic Procedures: A Review of Literature
  95. Insight into the Isolation, Synthesis, and Structure-Activity Relationship of Piperine Derivatives for the Development of New Compounds: Recent Updates
  96. 1,3,4-Oxadiazoles as Potential Pharmacophore for Cytotoxic Potentiality: A Comprehensive Review
  97. Synthesis Characterization and Antibacterial Activity of Terazosin Hydrochloride Drug and Market Formulation
  98. Benzimidazole-Quinoline Hybrid Scaffold as Promising Pharmacological Agents: A Review
  99. Validated HPLC‐UV method for simultaneous quantification of phosphatidylinositol 3‐kinase inhibitors, copanlisib, duvelisib and idelalisib, in rat plasma: Application to a pharmacokinetic study in rats
  100. An Overview of Bioactive Alkaloid, Semi-Synthetic Analogs, Mechanism of Action and Structure-Activity Relationship of Piperine as Antioxidant
  101. Design, Synthesis and in vitro Antibacterial Evaluation of Naphthalen-2-yloxy based Oxadiazole-2-thione Derivatives
  102. Pyridine Moiety: Recent Advances in Cancer Treatment
  103. Recent Development in Nuclear Magnetic Resonance as a Technique for Quantitative Method Validation
  104. Synthesis and Anticancer Potentials of Quinoline Analogues: A Review of Literature
  105. Synthesis and Biological Potentials of Quinoline Analogues: A Review of Literature
  106. Synthesis, Characterization and Anticonvulsant Potential of 2,5-Disubstituted 1,3,4-Oxadiazole Analogues
  107. Onosma L.: A review of phytochemistry and ethnopharmacology